Herliyantina, Anita (2025) Gambaran Penggunaan Obat Kelasi Besi Pada Pasien Thalasemia Periode Bulan Januari-Juni 2024 di RSU Prasetya Bunda Kota Tasikmalaya. Diploma thesis, Politeknik kesehatan tasikmalaya.
![[img]](http://repo.poltekkestasikmalaya.ac.id/style/images/fileicons/text.png) |
Text (Pernyataan Orisinalitas)
orisinalitas.pdf Download (160kB) |
|
Text
pengesahan stempel scan.pdf Download (268kB) |
|
Text (Persetujuan Publikasi)
persetujuan publikasi.pdf Download (1MB) |
|
Text (Halaman Judul)
HALAMAN JUDUL.pdf Download (1MB) |
|
Text (BAB 1)
BAB 1.pdf Download (406kB) |
|
Text (BAB 2)
BAB 2.pdf Restricted to Repository staff only Download (607kB) |
|
Text (BAB 3)
BAB 3.pdf Restricted to Repository staff only Download (673kB) |
|
Text (BAB 4)
BAB 4.pdf Restricted to Repository staff only Download (550kB) |
|
Text (BAB 5)
BAB 5.pdf Restricted to Repository staff only Download (371kB) |
|
Text (Daftar Pustaka)
DAFTAR PUSTAKA.pdf Restricted to Repository staff only Download (487kB) |
|
Text (Lampiran)
LAMPIRAN.pdf Restricted to Repository staff only Download (1MB) |
Abstract
Thalassemia sufferers have abnormalities in hemoglobin so that they require regular blood transfusions throughout their lives. This causes the accumulation of Fe in the body so that thalassemia sufferers need iron chelating drugs to remove excess Fe. The Chairperson of the Association of Parents of Indonesian Thalassemia Sufferers (POPTI) said that 100 sufferers were in Tasikmalaya City and 180 people in Tasikmalaya Regency. Prasetya Bunda Hospital is a hospital that provides a thalassemia center. Therefore, this study aims to describe the use of iron chelating drugs in thalassemia patients from January to June 2024 at Prasetya Bunda Hospital. The method applied is a quantitative descriptive approach using secondary data from patient medical records. The population in this study included all thalassemia patients who underwent blood transfusions at Prasetya Bunda Hospital from January to June 2024, totaling 191 people. Sampling was carried out through purposive sampling with a total sample of 66 patients. The results of the study showed that thalassemia patients were more common in men (60.6%) with the largest age range being children (81.8%). Thalassemia treatment based on the most commonly used type of drug was deferiprone (51.5%) with the highest dose of 500 mg 3x1 tablet (22.7%). All patients were in the category of thalassemia major, which is the most severe clinical condition of thalassemia.
| Item Type: | Thesis (Diploma) |
|---|---|
| Uncontrolled Keywords: | katastropik, kelasi besi, thalasemia |
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Divisions: | Jurusan Farmasi > D3 Farmasi |
| Depositing User: | Mhs Anita Herliyantina |
| Date Deposited: | 28 Jul 2025 03:02 |
| Last Modified: | 28 Jul 2025 03:02 |
| URI: | http://repo.poltekkestasikmalaya.ac.id/id/eprint/5904 |
Actions (login required)
 |
View Item |